Rodriguez 2000.
Methods | Placebo‐controlled, parallel‐arm study One centre in Spain Period of inclusion: June to October 1999 |
|
Participants |
Inclusion criteria
Exclusion criteria
Baseline data: participants received 20% aqueous solution of aluminium chloride hexahydrate (n = 6) or placebo (n = 6)
Withdrawal: no dropouts |
|
Interventions |
Intervention 1 A: 20% aqueous solution of aluminium chloride hexahydrate (6 participants) Intervention 2 B: placebo (6 participants) Co‐interventions: none Duration of treatment: 5 months |
|
Outcomes | No primary or secondary outcome pre‐specified
|
|
Notes | Funding: not reported | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Comment: study authors mentioned that the study is blinded, randomised, and controlled with placebo |
Allocation concealment (selection bias) | Unclear risk | Comment: not clear |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Comment: study authors mention in the methods that the study is blinded, even though in the abstract they say it is an open study |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Comment: study authors mention in the methods that the study is blinded, even though in the abstract they say it is an open study |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Comment: no dropouts |
Selective reporting (reporting bias) | Unclear risk | Comment: no protocol found to guarantee that all planned outcomes are presented in the results |